LLY
Eli Lilly and Company
LLY has the edge over SNDA overall, supported by stronger fundamentals and stronger modeled upside.
SNDA
Sonida Senior Living, Inc.
SNDA's outlook is improving, though it still trails on the overall score.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
SNDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Weak | |
| Weak |
SNDA's revenue is currently strong, but its profitability, cash flow and balance sheet are weak.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
SNDA PE Valuation
SNDA has no meaningful PE right now: it lost money over the past year.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
SNDA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect SNDA's losses to shrink, with revenue growing.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over SNDA on earnings quality, reporting a profit while its opponent remains loss making.
SNDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$5.36 | -$2.01 |
| Q2 2026 | -$6.20 | -$3.43 |
| Q1 2026 | -$5.84 | -$2.37 |
| Q4 2025 | -$4.22 | -$3.68 |
| Q3 2025 | -$3.35 | -$1.96 |
| Q2 2025 | -$2.77 | +$0.43 |
| Q1 2025 | -$3.47 | +$0.98 |
| Q4 2024 | -$0.54 | +$3.31 |
SNDA is still losing money, but far less than before: $5.36 per share over the past year, against $134.88 at its worst in late 2020.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the edge over SNDA on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY has the edge over SNDA on profitability, with a higher operating margin.
SNDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $210.2M | +114% |
| Q2 2026 | $207.6M | +122% |
| Q1 2026 | $122.6M | +33% |
| Q4 2025 | $97.7M | +6.2% |
| Q3 2025 | $98M | +31% |
| Q2 2025 | $93.5M | +33% |
| Q1 2025 | $91.9M | +36% |
| Q4 2024 | $91.9M | +40% |
SNDA's revenue has grown year over year for 18 quarters in a row: $210M last quarter, up 114% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -9.3% | +6.5 points |
| Q2 2026 | -2.6% | -0.2 points |
| Q1 2026 | -24% | -46 points |
| Q4 2025 | -22% | -15 points |
| Q3 2025 | -16% | -9.2 points |
| Q2 2025 | -2.4% | -0.4 points |
| Q1 2025 | 22% | +25 points |
| Q4 2024 | -7% | -0.1 points |
SNDA's operating margin was −9.3% last quarter, up 6.5 points from the same quarter a year ago.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the edge over SNDA on cash generation, producing positive trailing cash flow while its opponent burns cash.
SNDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $13.6M | +360% |
| Q2 2026 | -$3.7M | -292% |
| Q1 2026 | -$42.6M | -$38.1M |
| Q4 2025 | -$9.3M | +$1.1M |
| Q3 2025 | $3M | +$8M |
| Q2 2025 | $1.9M | +$3.6M |
| Q1 2025 | -$4.5M | +$5.4M |
| Q4 2024 | -$10.4M | -$6.6M |
SNDA has burned cash in most quarters: −$42M over the past year, against −$10M the year before.
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has the edge over SNDA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
SNDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.8% | +821K shares |
| 1 year | +163% | +29.5M shares |
| 3 years | +649% | +41.3M shares |
| 5 years | +2077% | +45.4M shares |
SNDA has 48M diluted shares, up 163% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2022 | $44,000 |
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY has the edge over SNDA on leverage, with a lower net debt burden relative to earnings.
SNDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 32.9x | High |
| Q2 2026 | 72.2x | High |
| Q4 2025 | 18.1x | High |
| Q3 2025 | 13.0x | High |
| Q2 2025 | 11.5x | High |
| Q1 2025 | 11.5x | High |
| Q4 2024 | 21.7x | High |
| Q3 2024 | 20.8x | High |
SNDA's net debt is more than 20 years of its operating earnings (EBITDA), up from 11 years a year ago.
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
SNDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.7 | Neutral |
| Stochastic | 9.7 | Oversold |
SNDA's weekly RSI is 39 (neutral) and its Stochastic is 10 (oversold).
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
SNDA PE vs Healthcare Sector
| Metric | SNDA | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
SNDA has no meaningful PE right now: it lost money over the past year.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over SNDA on trend strength, trading above more of its moving averages.
SNDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $35.0 | 5.3% below |
| 20 week MA | $37.9 | 12% below |
| 50 week MA | $35.7 | 7% below |
| 100 week MA | $30.4 | 9.1% above |
| 200 week MA | $23.7 | 40% above |
SNDA has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 40% above its 200-week average.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over SNDA on returns for 2026, with the stronger performance.
SNDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $47.6 | $12.9 | -73% |
| 2021 | $12.9 | $28.6 | +122% |
| 2022 | $28.6 | $11.7 | -59% |
| 2023 | $11.7 | $9.66 | -17% |
| 2024 | $9.66 | $22.9 | +137% |
| 2025 | $22.9 | $32.3 | +41% |
| 2026 YTD | $32.3 | $33.2 | +2.8% |
SNDA's yearly returns have swung widely, from +137% in 2024 to −73% in 2020. It's up 2.8% so far in 2026.